Dow Agro CEO retiring as divesture speculation returns
Dow AgroSciences is getting a new chief, the company said Friday. Meanwhile, the CEO of parent company Dow Chemical says Dow Agro could be sold off in a year or two.
Health Care & Life Sciences
Articles
Lilly diabetes drug wins backing from EU regulator
Indianapolis-based Lilly is expected to garner $518 million in annual sales from Jardiance by 2019, according to the average of five analyst estimates compiled by Bloomberg.
WellPoint raises 2014 earnings forecast
WellPoint is already raising a 2014 earnings forecast it laid out earlier this year, but the nation’s second-largest health insurer’s projections are still below analyst expectations.
Bold developer stirs up nursing-home business
Zeke Turner, the 36-year-old CEO of Mainstreet Property Group LLC—who frequently sports a boyish grin and a bold-colored dress shirt, but rarely dons a tie—said he’s “just getting started” in transforming the staid nursing home industry.
Top 10 most profitable hospitals around Indianapolis
Based on 2012 data, 23 of 30 hospitals in central Indiana are generating profits from their operations of 10 percent or more. The Indiana Orthopaedic Hospital and St. Vincent's Carmel campus are on top. After that, there are a few surprises.
Discovery may be key to Alzheimer’s treatment
Scientists have discovered that a gene-regulating protein that protects the developing brain of a fetus resurfaces in old age and may stave off dementia, a finding that could open a new path in Alzheimer’s research.
Obamacare shuffles market share in some states, report finds
A snapshot of Obamacare enrollment in seven states suggests the law hasn’t significantly increased competition, but it has shuffled market share for some insurers, including Indianapolis-based WellPoint Inc.
Can we, please, get a better name than ‘accountable care’?
Health care is going through dramatic change—but is doing so under some of the dullest names possible. So I’m offering a few alternatives that are more to the point. How about, ‘No-more-bankruptcy care’?
Hurdles remain for Roche Diagnostics on HPV test
Roche could enjoy a huge increase in sales of its HPV tests if all doctors and women followed a recommendation issued last week by an advisory committee at the FDA. But wrinkles in the U.S. health care system still present several big obstacles.
Biomet plans $40.5 million upgrade, 150 jobs
Biomet’s project calls for building renovations and adding 3-D printing and optical scanning technology. The Warsaw-based company would also upgrade an incubation center for surgeons interested in introducing a new product, technology or technique.
Anthem, Franciscan sign accountable care contract
Anthem Blue Cross and Blue Shield has signed a new kind of contract with the Franciscan Alliance hospital system that allows Franciscan to make more money only if it saves money for Anthem.
In one chart: Obamacare exchange has failed to expand coverage in Indiana
For 2014, at least, Obamacare's dreams of expanding individual insurance coverage in Indiana have simply failed. There's no getting around it.
WellPoint getting unexpected competition from co-ops
Obamacare opponents predicted early on that insurance co-ops created by the law would fail, but several are doing well by combining low premiums with a certain homespun appeal.
Federal insurance enrollment up 36 percent in Indiana
Nearly 65,000 Indiana residents have signed up for private insurance under the federal health care law, but the number is still far short of initial projections as the open enrollment deadline nears.
Lawmakers getting closer on nursing home moratorium
House Public Health Chairman Ed Clere said Tuesday that negotiators had found a compromise that would ban new construction for two years except in counties whose nursing homes are at 90-percent capacity or higher.
Companies, including WellPoint, use buybacks to boost stock
Companies have been spending big on buybacks since the 1990s. What's new is the way buybacks have exaggerated the health of many companies.
Purdue-based cancer imaging firm lands $15M in funding
OnTarget Laboratories LLC’s technology was developed by Philip Low, a Purdue chemistry professor who also created the technology behind Endocyte Inc.
Republicans needed to make Obamacare work
Obama’s latest delay of Obamacare insurance rules could sabotage the law’s exchanges. The president must be counting on Republican critics, like Indiana Insurance Commissioner Stephen Robertson, to stop him.
Timing looks right for Biomet IPO
After private equity firms paid $11.4 billion for Biomet Inc. just months before the onset of a prolonged downturn, they are now trying to take the company public when U.S. consumer sentiment is on the upswing.
Health insurance brokers must change to survive
Employees, rather than employers, will soon choose their own health insurers—either through the Obamacare exchanges or through private exchanges. Does that mean health insurance brokers, the people who match up employers with insurers, will no longer be needed?